India Gourmet and Medicinal Mushroom Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

India Gourmet and Medicinal Mushroom Overview

The India gourmet and medicinal mushroom market was valued at USD 872.07 million in 2025 and is projected to reach USD 2,278.37 million by 2033, growing at a CAGR of 13.0% from 2026 to 2033. The increasing demand for nutritious, functional, and health-oriented foods is a key factor driving market growth. Rising consumer awareness regarding the nutritional and potential wellness benefits of mushrooms is encouraging greater adoption of gourmet and medicinal varieties. Demand is also increasing from restaurants, hotels, food processors, nutraceutical manufacturers, and health-conscious consumers seeking natural ingredients and plant-based alternatives. Gourmet mushrooms such as shiitake, oyster, king oyster, and lion’s mane are gaining popularity due to their culinary applications and nutritional value, while medicinal varieties such as reishi, cordyceps, turkey tail, and tremella are increasingly incorporated into supplements, functional beverages, and wellness products.

Furthermore, expanding urbanization, improving cold-chain and distribution infrastructure, e-commerce penetration, and the emergence of controlled-environment cultivation are supporting market accessibility and supply consistency. Growing interest in immunity, preventive wellness, clean-label products, and sustainable food sources is expected to create additional opportunities. However, limited consumer awareness, perishability, inconsistent quality, higher production costs, and limited cultivation expertise remain important challenges for market participants.

Key Market Trends & Insights

• The button mushroom segment led the market with a 75.86% share in 2025, owing to its widespread consumer acceptance, affordability, established cultivation practices, and extensive use across households, restaurants, hotels, foodservice establishments, and processed-food applications. Button mushrooms are readily available through established retail and wholesale networks and benefit from strong domestic production.
• The Reishi segment is projected to be the fastest-growing material type, with a CAGR of 14.6% during the forecast period, reflecting increasing consumer interest in medicinal mushrooms and functional wellness products.
• The wet / fresh segment dominated the market with a 65.54% revenue share in 2025, driven by its strong consumer preference, broad culinary applications, nutritional appeal, and extensive utilization across households and foodservice establishments. Fresh mushrooms are commonly consumed in everyday meals and are increasingly available through supermarkets, modern trade outlets, local retailers, and online grocery platforms.
• The extract segment is projected to be the fastest-growing material type, with a CAGR of 13.9% during the forecast period, owing to its increasing use in nutraceuticals, dietary supplements, functional foods, beverages, cosmetics, and wellness formulations. Mushroom extracts provide concentrated functional compounds and offer convenient incorporation into various products.
• The B2B segment dominated the market with a 68.14% revenue share in 2025, driven by strong demand from restaurants, hotels, food processors, wholesalers, retailers, institutional buyers, and nutraceutical manufacturers. Bulk procurement, recurring orders, established distribution networks, and long-term supplier relationships support the segment’s leading position. Commercial foodservice and processing applications require consistent mushroom supplies, further strengthening B2B demand across India.
• The B2C segment is projected to be the fastest-growing material type, with a CAGR of 13.6% during the forecast period, owing to increasing direct consumer purchases, rising health consciousness, expanding e-commerce adoption, and growing household consumption of gourmet and medicinal mushrooms.
• The online retailers segment is projected to be the fastest-growing material type, with a CAGR of 14.0% during the forecast period, owing to increasing internet penetration, convenience-oriented shopping behavior, wider product availability, and growing consumer acceptance of online grocery and wellness purchases.

Market Size & Forecast

• Market Value (2025): USD 872.07 Million
• Expected Market Value (2033): USD 2,278.37 Million
• Forecast CAGR (2026–2033): 13.0%

Report Scope and India Gourmet and Medicinal Mushroom Segmentation         

India Gourmet and Medicinal Mushroom Trends

Trend: Rising Adoption of Medicinal and Functional Mushrooms

India’s gourmet and medicinal mushroom market is increasingly shifting toward medicinal and functional mushroom products, supported by growing consumer awareness of wellness, nutrition, immunity, and natural health ingredients. Reishi, Lion’s Mane, Cordyceps, and other specialty varieties are gaining attention across nutraceuticals, dietary supplements, functional beverages, and wellness formulations. This trend is encouraging growers and businesses to diversify beyond conventional button mushrooms and develop higher-value products.

For instance,

• In April 2026, ICAR-KVK Namsai inaugurated a mushroom spawn production laboratory in Arunachal Pradesh to improve farmers’ access to quality spawn and support organized mushroom cultivation.
• In June 2026, the XXVIII AICRP-Mushroom Workshop held in Guwahati emphasized specialty mushrooms, sustainable production technologies, quality spawn, and value-added mushroom products, highlighting the increasing focus on diversification and commercialization.

The growing emphasis on medicinal and specialty mushrooms is expected to encourage product innovation, advanced cultivation, and expansion of India’s functional mushroom industry.

India Gourmet and Medicinal Mushroom Market Dynamics

Key Market Driver: Growing Adoption of Specialty Mushroom Cultivation

The growing adoption of specialty mushrooms is emerging as an important driver of diversification within India’s mushroom cultivation industry. Traditionally, Indian mushroom production has been strongly associated with button mushrooms; however, increasing interest in oyster, shiitake, milky, king oyster, lion’s mane, Ganoderma, Cordyceps and other specialty varieties is expanding the addressable cultivation base. Specialty mushrooms provide growers with opportunities to differentiate their production based on local agro-climatic conditions, culinary applications, nutritional attributes and premium-market positioning. This is particularly relevant for small and marginal farmers because several specialty varieties can be cultivated using locally available agricultural residues and comparatively smaller production infrastructure. The development of region-specific cultivation technologies is also reducing the technical barriers associated with specialty mushroom production.

The institutional ecosystem is increasingly supporting this transition. ICAR's Directorate of Mushroom Research (DMR), Solan has historically worked on improved oyster and shiitake varieties, medicinal mushrooms and other specialty species. Its technology portfolio has included improved varieties of oyster and shiitake mushrooms as well as cultivation technologies for medicinal mushrooms such as Cordyceps militaris. This creates a stronger technological foundation for commercial growers to move beyond conventional button mushroom cultivation.

• A recent India-specific instance is Arunachal Pradesh, where ICAR reported successful cultivation of king oyster mushroom (Pleurotus eryngii) under mid-hill conditions in January 2026. The mushroom was cultivated on paddy straw under controlled environmental conditions and demonstrated healthy and uniform fruiting, indicating the potential for specialty mushroom diversification in the region.
• Another example comes from Uttarakhand, where an entrepreneur supported through the KVK ecosystem diversified from conventional mushroom cultivation into shiitake and Ganoderma, alongside developing a year round production operation. The enterprise subsequently developed value-added products including mushroom pickle, cookies, nuggets, soup, protein powder, tea and papad. The growing institutional emphasis on specialty mushrooms is also evident from the 2026 AICRP-Mushroom workshop in Guwahati, where ICAR specifically encouraged North-Eastern centres to promote specialty mushrooms because of the limited availability of wheat straw required for button mushroom cultivation.

Consequently, specialty mushroom cultivation is being driven by crop diversification, premium product opportunities, regional agro-climatic suitability, availability of alternative substrates, nutritional/functional-food positioning and technology transfer. These factors are expected to progressively broaden India's mushroom production portfolio beyond button mushrooms.  

Key Restraint/Challenge: Limited Availability of Quality Spawn

Limited availability of quality, contamination-free and locally accessible mushroom spawn remains a structural restraint for the expansion of India's mushroom cultivation industry. Spawn is the critical biological input from which commercial mushroom production begins, and its quality directly influences colonization, yield, crop uniformity and contamination risk. Unlike conventional agricultural seeds, mushroom spawn requires controlled laboratory production and appropriate storage and handling. Consequently, farmers in regions without reliable spawn laboratories may need to procure spawn from distant suppliers, increasing procurement costs, transportation time and the risk of quality deterioration. This constraint is particularly significant for emerging mushroom-producing regions, where cultivation is expanding faster than local input infrastructure.

The issue is explicitly recognized by India's institutional mushroom ecosystem. ICAR has highlighted the need to strengthen spawn production and establish spawn certification mechanisms to ensure the availability of quality spawn for mushroom growers.

• At the XXVIII AICRP-Mushroom Workshop held in Guwahati in 2026, ICAR specifically called for strengthening spawn production across North-Eastern centres and establishing a robust certification mechanism. The Assam Government also highlighted the need to strengthen spawn availability and reported financial assistance for establishment of spawn laboratories.
• A clear India-specific example comes from Nalanda, Bihar. ICAR documented the experience of a mushroom entrepreneur who initially had to procure spawn from Delhi and Ranchi at high cost because there was no mushroom spawn laboratory in Nalanda district. This supply constraint subsequently became the motivation for establishing the Buddha Mushroom Spawn Laboratory at Rajgir with technical support from KVK Nalanda and ICAR-DMR, Solan. The laboratory eventually scaled its production to approximately 700 kg and supplied spawn across Bihar, Jharkhand, eastern Uttar Pradesh and Chhattisgarh.
• A similar challenge has been documented in Meghalaya, where ICAR identified the availability of quality spawn as a major constraint to sustainable oyster mushroom farming. An entrepreneur from Ri-Bhoi district specifically underwent training in spawn production after identifying the gap in quality spawn supply.
• The problem is also evident in Namsai, Arunachal Pradesh, where ICAR-KVK Namsai established a dedicated mushroom spawn laboratory in April 2026 specifically to address the long-standing need for timely, reliable and affordable quality spawn and reduce farmers' dependence on external sources.

Therefore, inadequate regional spawn infrastructure creates a chain of constraints involving higher input costs, delayed production cycles, contamination risk, inconsistent yields and geographic limitations on cultivation. Until decentralized spawn laboratories, quality standards, certification systems and efficient distribution networks become more widespread, spawn availability will remain a key bottleneck for India's mushroom industry.  

Key Market Opportunity: Commercialization of Specialty Varieties

The commercialization of specialty mushroom varieties represents a significant opportunity for India to diversify beyond the traditionally dominant button and oyster mushroom segments and develop higher-value product categories. Specialty varieties such as lion’s mane, shiitake, king oyster, milky mushroom, reishi and Cordyceps can command differentiated pricing because of their distinctive culinary characteristics, nutritional profiles and, in some cases, functional or medicinal positioning. Commercialization can therefore shift the industry from a predominantly volume-oriented fresh-mushroom model toward a portfolio comprising premium fresh mushrooms, dried products, powders, extracts and functional-food ingredients. This opportunity is particularly relevant for India's diverse agro-climatic conditions, where different mushroom species can be matched with specific regional production environments.

India already possesses an institutional foundation for this opportunity. ICAR has developed and documented several specialty mushrooms, including Macrocybe gigantea, Pleurotus tuber-regium, Hericium erinaceus (lion's mane), Lentinula edodes (shiitake) and Ganoderma lucidum (reishi) using locally available substrates. ICAR's landmark-variety portfolio also includes Arka Lion's Mane, described as an edible and medicinal mushroom containing beta-glucan polysaccharides and minerals such as zinc, potassium and calcium.

• A particularly relevant recent instance is Arunachal Pradesh, where ICAR successfully demonstrated commercial cultivation of king oyster mushroom (Pleurotus eryngii) under mid-hill conditions. The crop cycle was completed within 30–35 days and achieved reported biological efficiency of 80–85%. ICAR also highlighted that the AICRP Mushroom centre at Basar provides training and quality spawn to interested growers, creating the foundation for scaling the variety beyond research trials.
• Another important commercialization opportunity is the development of region-specific specialty mushroom clusters. North-Eastern India, for example, possesses substantial agricultural residues that can potentially serve as cultivation substrates. ICAR has explicitly highlighted specialty mushrooms as an opportunity for the region, where conventional button mushroom cultivation can be constrained by substrate availability. The 2026 AICRP Mushroom workshop in Guwahati brought together researchers, policymakers, extension personnel and farmers to advance sustainable production and innovation in the sector.

Commercialization can also be supported by differentiated channels such as premium restaurants, modern retail, health-food stores, e-commerce and direct-to-consumer platforms. For producers, this creates opportunities to capture greater value through species differentiation, controlled-environment cultivation, premium packaging, branding and processed specialty-mushroom products.

Thus, India's specialty-mushroom opportunity extends beyond increasing cultivation volumes. It can create a new value chain encompassing specialty spawn, controlled cultivation, premium fresh products, dried/powdered products, functional foods, branded consumer products, thereby increasing value realization for growers and processors.

India Gourmet and Medicinal Mushroom Market Scope

The gourmet and medicinal mushroom market is segmented into four notable segments based on mushroom, product category, business model, and sales channel.

• By Mushroom

On the basis of mushroom, the market is segmented into Button Mushroom, Shiitake (Lentinula Edodes), Reishi (Ganoderma Lucidum) Black Fungus/Wood Ear (Auricularia spp.), Lion’s Mane (Hericium Erinaceus), King Oyster (Pleurotus Eryngii), Cordyceps Militaris, Turkey Tail (Trametes Versicolor), and Snow Fungus (Tremella Fuciformis). In 2025, the button mushroom segment is expected to dominate the India gourmet and medicinal mushroom market with a market share of 75.86% due to its widespread consumer acceptance, affordability, established cultivation practices, year-round availability, nutritional value, and extensive use across households, restaurants, hotels, foodservice, and processed-food applications. Strong domestic production and well-established distribution networks further contribute to its significant market presence across India.

The Reishi (Ganoderma Lucidum) segment is projected to register the fastest CAGR of 14.6% from 2026 to 2033. Growth is driven by widespread consumer acceptance, affordability, established cultivation practices, year-round availability, nutritional value, and extensive use across households, restaurants, hotels, foodservice, and processed-food applications. Strong domestic production and well-established distribution networks further contribute to its significant market presence across India.

• By Product Category

On the basis of product category, the market is segmented into wet / fresh, dry, and extract. In 2025, the wet / fresh segment is expected to dominate the market with a share of 65.54% due to its strong consumer preference for fresh produce, extensive culinary applications, nutritional benefits, and growing consumption among households and foodservice establishments. Increasing availability through supermarkets, modern retail, local stores, and online grocery platforms, along with rising demand for minimally processed foods, further supports segment growth.

The extract segment is projected to register the fastest CAGR of 13.9% from 2026 to 2033. The fast growth is mainly driven by increasing utilization of mushroom extracts in nutraceuticals, dietary supplements, functional beverages, wellness products, cosmetics, and health-focused formulations. Extracts provide concentrated functional compounds and convenient incorporation into various products. Rising consumer interest in natural ingredients, preventive wellness, immunity-focused products, and functional nutrition is expected to encourage manufacturers to expand mushroom-based extract offerings across India.

• By Business Model

On the basis of business model, the market is segmented into B2B, and B2C. In 2025, the B2B segment is expected to dominate the market with a share of 68.14% due to its substantial demand from restaurants, hotels, food processors, wholesalers, retailers, institutional buyers, and nutraceutical manufacturers. Bulk procurement, recurring orders, established distribution networks, and commercial-scale requirements support the segment. Increasing mushroom utilization in foodservice, processing, and ingredient applications further strengthens B2B demand across India.

The B2C segment is expected to experience the fastest CAGR of 13.6% from 2026 to 2033, driven by increasing consumer health awareness, rising household mushroom consumption, expanding e-commerce adoption, and greater availability of gourmet and medicinal mushroom products. Consumers are increasingly seeking convenient access to fresh, dried, powdered, and functional mushroom products. Direct-to-consumer platforms, digital marketing, home delivery, and changing preferences toward nutritious and plant-based foods are expected to further support B2C expansion.

• By Sales Channel

On the basis of sales channel, the market is segmented into B2B sales, modern trade, food services, online retailers, chemists / pharmacies, exports, and others. In 2025, the B2B sales segment is expected to dominate the market with a share of 28.36% due to the bulk procurement from wholesalers, distributors, restaurants, hotels, food processors, retailers, and institutional buyers. Recurring orders, established supplier relationships, larger transaction volumes, and efficient distribution networks contribute to strong commercial demand. Expanding foodservice and processing applications further strengthen B2B sales across India.

The online retailers segment is expected to experience the fastest CAGR of 14.0% from 2026 to 2033, supported by increasing internet and smartphone penetration, rising consumer preference for convenient shopping, expanding e-commerce platforms, and broader availability of gourmet and medicinal mushroom products. Online channels provide access to fresh, dried, powdered, and functional mushroom products while enabling home delivery and digital product discovery. Increasing digital marketing and changing purchasing habits are expected to accelerate online retail adoption.

India Gourmet and Medicinal Mushroom Market Share

The India gourmet and medicinal mushroom industry is primarily led by well-established companies, including:

• INVENTAA INDUSTRIES PRIVATE LIMITED (India)
• Nuvedo (India)
• Flex Foods Limited (India)
• Ambrosiya Neo Medicine (India)
• Planet Mushroom (India)
• Himalaya Food International Ltd. (India)
• Ace Blend (India)
• Shroomery (India)
• Soma (India)
• Bombay Farming Co (India)
• Gourmet Mushroom Company (India)
• Octarine Organics Private Limited (India)
• Azoth Biotech (India)
• The Fungamental Co. (India)
• Green Apron Farms (India)
• AL Baraka Mushrooms (India)
• Mycelium India Biotech (India)
• BM Mushroom (India)
• Umbrella Agro Tech (India)
• Verma Mushroom House (India)
• Good Mushroom PVT LTD (India)

Latest Developments in India Gourmet and Medicinal Mushroom Market

• In March 2026, Himalaya Food International expanded its international presence by launching Frozen Cinnamon French Toast Sticks in the UK and securing Regular Approved Vendor status with US Foods. The development strengthens the company’s access to European and North American foodservice markets, while supporting broader export diversification and future opportunities to expand its frozen food portfolio across international distribution networks.
• In February 2026, Himani Garg, founder of SomaShrooms, received the SIWAA “Outstanding Entrepreneur” Award for her contribution to India’s functional mushroom industry. The development highlights SomaShrooms’ focus on technology driven cultivation, product innovation, farmer empowerment, and sustainable agriculture. Garg also received the ICAR-IIHR products. “Best Farmer of India 2025” recognition, reinforcing her role in advancing mushroom farming and functional wellness
• In 2025, Planet Mushroom expanded its mushroom portfolio by diversifying beyond button mushrooms into exotic varieties including Shiitake, Cordyceps, Lion’s Mane, Reishi, and King Oyster. The company also achieved a significant cultivation milestone by commercially growing wild Gucchi mushrooms indoors in Uttarakhand, marking a notable development in India’s exotic mushroom industry and strengthening Planet Mushroom’s position in specialty mushroom cultivation.
• In April 2022, Mycelium Sona Biotech inaugurated its first laboratory in Salem to cultivate medicinal mushrooms and develop nutraceutical products. The facility planned to cultivate 16 medicinal mushroom strains, extract bioactive compounds, and produce food-grade and nutraceutical-grade products. The company also announced partnerships for research and global expansion, with plans to obtain certifications enabling exports to Australia, the U.S., and Europe.
• In February 2022, Ambrosiya Neo-Medicine highlighted India’s updated Food Safety and Standards regulations concerning mandatory fortification of vegetable oils and milk with essential micronutrients. The company emphasized its vegan Vitamin D3 as a domestic alternative for food manufacturers, particularly amid changing import conditions, positioning its plant-based solution to support regulatory compliance and the growing demand for sustainable vitamin fortification.